{"id":"https://openalex.org/A5012467330","orcid":null,"observed_orcids":[],"display_name":"Yuki Iwayanagi","raw_author_names":["Y Iwayanagi","Yuki Iwayanagi"],"full_name":"Yuki Iwayanagi","works_count":12,"cited_by_count":600,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":11,"i10_index":11},"ids":{"openalex":"https://openalex.org/A5012467330","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210109338","ror":"https://ror.org/022cvpj02","display_name":"University of Tokyo Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210109338"]},"years":[2010,2007,2006]},{"institution":{"id":"https://openalex.org/I4405254473","ror":"https://ror.org/01v743b94","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},"years":[2018,2017,2016,2015,2013]},{"institution":{"id":"https://openalex.org/I74801974","ror":"https://ror.org/057zh3y96","display_name":"The University of Tokyo","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]},"years":[2010,2007,2006]}],"last_known_institutions":[{"id":"https://openalex.org/I4405254473","ror":"https://ror.org/01v743b94","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":8,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":4,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","count":3,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":4.67e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","value":2.94e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":2.3e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":2.29e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","value":2.09e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","score":0.8523528575897217},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.646478533744812},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.5400351881980896},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.515177845954895},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.47122183442115784}],"counts_by_year":[{"year":2006,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2007,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2010,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":6},{"year":2013,"works_count":1,"oa_works_count":1,"cited_by_count":19},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":9},{"year":2015,"works_count":3,"oa_works_count":2,"cited_by_count":19},{"year":2016,"works_count":1,"oa_works_count":0,"cited_by_count":19},{"year":2017,"works_count":3,"oa_works_count":3,"cited_by_count":43},{"year":2018,"works_count":1,"oa_works_count":1,"cited_by_count":42},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":39},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":37},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":48},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":55},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":64},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":43},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":63},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":47}],"display_name_alternatives":["Y Iwayanagi","Yuki Iwayanagi"],"block_key":"y iwayanagi","works_api_url":"https://api.openalex.org/works?filter=author.id:A5012467330","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5012467330","updated_date":"2026-11-21T13:19:37","created_date":"2016-06-24T00:00:00"}
